×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BMEA – biomea fusion, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BMEA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/26
01:06 pm
bmea
Biomea Fusion, Inc. (NASDAQ: BMEA) was given a new $10.00 price target on by analysts at Oppenheimer Holdings Inc..
Low
Report
Biomea Fusion, Inc. (NASDAQ: BMEA) was given a new $10.00 price target on by analysts at Oppenheimer Holdings Inc..
3/25
07:00 pm
bmea
Biomea Fusion Announces Leadership Transition
Medium
Report
Biomea Fusion Announces Leadership Transition
3/24
02:53 pm
bmea
Biomea Fusion, Inc. (NASDAQ: BMEA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Low
Report
Biomea Fusion, Inc. (NASDAQ: BMEA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
3/24
08:37 am
bmea
Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose [Yahoo! Finance]
Low
Report
Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose [Yahoo! Finance]
3/24
08:30 am
bmea
Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose
Medium
Report
Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose
3/19
08:04 am
bmea
Biomea Fusion, Inc. (NASDAQ: BMEA) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $16.00 price target on the stock.
Medium
Report
Biomea Fusion, Inc. (NASDAQ: BMEA) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $16.00 price target on the stock.
3/3
08:00 am
bmea
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
High
Report
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
2/27
08:00 am
bmea
Biomea Fusion to Unveil New Icovamenib Data at the 18th International Conference on Advanced Technologies & Treatments for Diabetes
Medium
Report
Biomea Fusion to Unveil New Icovamenib Data at the 18th International Conference on Advanced Technologies & Treatments for Diabetes
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
3/28
04:15 pm
bmea
Form 4 Biomea Fusion, Inc. For: Mar 26 Filed by: Hitchcock Michael J.M.
Medium
Report
Form 4 Biomea Fusion, Inc. For: Mar 26 Filed by: Hitchcock Michael J.M.
3/27
04:35 pm
bmea
Form 8-K Biomea Fusion, Inc. For: Mar 25
Medium
Report
Form 8-K Biomea Fusion, Inc. For: Mar 25
2/28
04:05 pm
bmea
Form 8-K Biomea Fusion, Inc. For: Feb 24
Medium
Report
Form 8-K Biomea Fusion, Inc. For: Feb 24
2/14
04:13 pm
bmea
Form SCHEDULE 13G/A Biomea Fusion, Inc. Filed by: BAKER BROS. ADVISORS LP
Medium
Report
Form SCHEDULE 13G/A Biomea Fusion, Inc. Filed by: BAKER BROS. ADVISORS LP
1/15
04:57 pm
bmea
Form 8-K Biomea Fusion, Inc. For: Jan 13
Medium
Report
Form 8-K Biomea Fusion, Inc. For: Jan 13
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: